Parrales and Iwakuma highlighted the potential exploitation of heterozygosity, during which mutant p53 acts as a DN over wt p53, hence targeting mutant p53 eliminates its oncogenic driver and concurrently restores the tumor suppressive capacity of wt p53. Here, TP53 is linked to neoplasm.